MedPath

Neurophysiological Measures of Auditory Perception and Rehabilitation in Cochlear Implanted Patients

Not Applicable
Completed
Conditions
Deafness
Registration Number
NCT02323256
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

This study aims at investigating new automatic fitting techniques for cochlear implant patients based on objective measures. For this reason, the evolution of these neurophysiological measures, expressing the encoding of pure tones and speech, will be characterized in cochlear implanted patients as a function of post-implantation time and will be compared to those of normal hearing subjects. Moreover, the effect of auditory training with new tools based on serious games will be assessed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
91
Inclusion Criteria
  • native French speaker
  • no medical treatment for behavior or neurological disorders
  • normal or corrected vision
  • right-handed
  • normal ORL examination
  • valid affiliation to social security
  • absence of participation to another study

For the cochlear implanted patients:

  • aged from 1 to 70
  • bilateral severe to profound deafness
  • cochlear implant
  • congenital deafness, pre or post lingual

For the normal-hearing subjects:

  • Aged from 18 to 70
  • Normal tonal audiometry
Exclusion Criteria
  • No signed consent
  • Treatment for depression, epilepsy, Parkinson's or Alzheimer's disease
  • Physical health deficiency
  • Mental retardation
  • Neurological or psychiatric disease incompatible with the testing procedure
  • Schooling in a foreign language
  • Foreign language spoken at home with both parents
  • Invalid social security
  • For the normal hearing subjects, no known hearing deficits

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Spectro-temporal analysis of speech-ABRone year at least after CI activation
Evolution of spectro-temporal analysis of speech-ABR1 month, 3 months, 6 months, 9 months and 12 months after CI activation

Evolution of spectro-temporal analysis of speech-ABR as a function of time during the first year of CI activation in newly implanted patients

Evolution of amplitude of auditory steady state responses ASSR1 month, 3 months, 6 months, 9 months and 12 months after CI activation

Evolution of ASSR amplitudes as a function of time during the first year of CI activation in newly implanted patients

amplitudes and latencies of P1/N1/P2 complex and Mismatch Negativity MMN1 month, 3 months, 6 months, 9 months and 12 months after CI activation

Evolution of amplitudes and latencies of P1N1P2 and MMN as a function of time during the first year of CI activation in newly implanted patients

Amplitude of auditory steady state responses ASSRone year at least after CI activation
Acoustic Change Complex ACC1 month, 3 months, 6 months, 9 months and 12 months after CI activation

Evolution of amplitudes and latencies of ACC as a function of time during the first year of CI activation in newly implanted patients

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospices Civils de Lyon - Hopital Edouard Herriot

🇫🇷

Lyon, France

Hospices Civils de Lyon - Hopital Edouard Herriot
🇫🇷Lyon, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.